MeVis Medical Solutions AGFRA:M3V 66 Dividend Yield % is 4.09% as of Jun. 27, 2026, which is 42% above its 10-year median of 2.88. GuruFocus rates FRA:M3V with a GF Score™ of 66/100 and a GF Value™ of €22.52. The stock has 4 warning signs investors should review. Among 281 Healthcare Providers & Services companies, MeVis Medical Solutions AG ranks better than 78.29% on this metric.
MeVis Medical Solutions AG stock Dividend Yield % is close to 10-year high.
The historical rank and industry rank for MeVis Medical Solutions AG's Dividend Yield % or its related term are showing as below:
FRA:M3V'
s Dividend Yield % Range Over the Past 10 Years
Min: 0.1 Med: 2.88 Max: 4.28
Current: 4.09
During the past 13 years, the highest Dividend Yield of MeVis Medical Solutions AG was 4.28%. The lowest was 0.10%. And the median was 2.88%.
FRA:M3V's Dividend Yield % is ranked better than 78.29% of 281
companies
in the Healthcare Providers & Services industry
Industry Median: 2.4
vs FRA:M3V: 4.09
If a company's dividend payout ratio is too high, its dividend may not be sustainable. The dividend payout ratio of MeVis Medical Solutions AG is 2.27, which seems too high.
During the past 13 years, the highest Dividend Payout Ratio of MeVis Medical Solutions AG was 2.27. The lowest was 0.01. And the median was 0.26.
During the past 13 years, the highest 3-Year average Dividends Per Share Growth Rate of MeVis Medical Solutions AG was 187.40% per year. The lowest was 10.00% per year. And the median was 98.70% per year.
The growth rate is calculated with least square regression.
For more information regarding to dividend, please check our Dividend Page.
* Please note that "special dividend" is not included in the calculation of dividend per share and related fields.
MeVis Medical Solutions AG (FRA:M3V) Dividend Yield % Explanation
Over the long term, the return from dividends has been a significant contributor to the total returns produced by equity securities. Studies by Elroy Dimson, Paul Marsh, and Mike Staunton of Princeton University (2002) found that a market-oriented portfolio, which included reinvested dividends, would have generated nearly 85 times the wealth generated by the same portfolio relying solely on capital gains.
Dividends may also qualify a lower tax rate for investors.
In dividends investing, Payout Ratio and Dividend Growth Rate are the two most important variables for consideration. A lower payout ratio may indicate that the company has more room to increase its dividends.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
FRA:M3V vs VEEV, BTSG, TEM: Dividend Yield % Comparison
For the Health Information Services subindustry, MeVis Medical Solutions AG's Dividend Yield %, along with its competitors' market caps and Dividend Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
MeVis Medical Solutions AG Dividend Yield % vs Healthcare Providers & Services Industry
For the Healthcare Providers & Services industry and Healthcare sector, MeVis Medical Solutions AG's Dividend Yield % distribution charts can be found below:
* The bar in red indicates where MeVis Medical Solutions AG's Dividend Yield % falls into.
MeVis Medical Solutions AG Dividend Yield % Calculation
Dividend Yield measures how much a company pays out in dividends each year relative to its share price.
MeVis Medical Solutions AG Recent Full-Year* Dividend History
Amount
Ex-date
Record Date
Pay Date
Type
Frequency
Forex Rate
EUR 0.950000
2026-03-20
2026-03-23
2026-03-24
Cash Dividend
annually
EUR:EUR 1.000000
* GuruFocus has an internal rule that if the most recent dividend payment frequency is at least 4 times a year, then the full year will be calculated according to the frequency of payment or the one-year time frame, whichever is stricter.
* GuruFocus converts dividend currency to local traded share price currency in order to calculate dividend yield. Please refer to the last column "Forex Rate" in the above table.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
MeVis Medical Solutions AG (FRA:M3V) has a Dividend Yield % of 4.09% as of Jun. 27, 2026. Dividend yield is the ratio of company dividends to the share price. View historical data on MeVis Medical Solutions AG and its competitors. This is 42% above median its historical median of 2.88. Over the past decade, MeVis Medical Solutions AG's Dividend Yield % has ranged from 0.10 to 4.28. According to the industry distribution chart, MeVis Medical Solutions AG ranks #61 out of 281 companies in the Healthcare Providers & Services industry, placing it in the top 21.7%.
Is MeVis Medical Solutions AG's Dividend Yield % too high?
MeVis Medical Solutions AG's current Dividend Yield % of 4.09% is 42% above median its 10-year median of 2.88. Over the past 10 years, this metric has ranged from a low of 0.10 to a high of 4.28. The Healthcare Providers & Services industry median Dividend Yield % is 2.40. MeVis Medical Solutions AG's value of 4.09% is 70.4% above this industry median. Based on the distribution chart, MeVis Medical Solutions AG ranks #61 out of 281 companies in the Healthcare Providers & Services industry, which is in the top quartile — a strong position relative to peers. Overall, MeVis Medical Solutions AG has a GF Score™ of 66/100, reflecting its overall financial health beyond just this single metric.
How does MeVis Medical Solutions AG's Dividend Yield % compare to VEEV and BTSG?
According to the Healthcare Providers & Services industry distribution chart, MeVis Medical Solutions AG ranks #61 out of 281 companies for Dividend Yield %. This places MeVis Medical Solutions AG in the top 22% of its industry — outperforming the majority of peers. The industry median Dividend Yield % is 2.40. MeVis Medical Solutions AG's value of 4.09% is 70.4% above this benchmark. Historically, MeVis Medical Solutions AG's own Dividend Yield % has ranged from 0.10 to 4.28 over the past decade. While the company's 10-year median is 2.88 vs. the industry median of 2.40, MeVis Medical Solutions AG has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Dividend Yield % for a Healthcare Providers & Services company?
The median Dividend Yield % among Healthcare Providers & Services companies is 2.40, based on 281 companies in the industry. Companies in the top quartile (top 25%) have a Dividend Yield % significantly above this median, while those in the bottom quartile fall well below. However, Dividend Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. MeVis Medical Solutions AG's current Dividend Yield % of 4.09% is 70.4% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Dividend Yield % mean?
A high Dividend Yield % can signal that a stock is expensive relative to its fundamentals. Dividend yield is the ratio of company dividends to the share price. View historical data on MeVis Medical Solutions AG and its competitors. For the Healthcare Providers & Services industry, the median Dividend Yield % is 2.40 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. MeVis Medical Solutions AG's current Dividend Yield % is 4.09%, which is 42% above median its own 10-year median of 2.88. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is MeVis Medical Solutions AG stock overvalued right now?
MeVis Medical Solutions AG (FRA:M3V) has a current Dividend Yield % of 4.09%. The stock's GF Value™ is €22.52, compared to a current price of €23.20 — trading 3% above its estimated fair value. The current Dividend Yield % is 4.09%, which is 42% above median its 10-year median of 2.88 and 70.4% above the Healthcare Providers & Services industry median of 2.40. MeVis Medical Solutions AG's overall GF Score™ is 66/100 with 4 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Dividend Yield % calculated?
Dividend Yield % is calculated from a company's financial statements. For MeVis Medical Solutions AG (FRA:M3V), the current Dividend Yield % is 4.09% as of Jun. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is MeVis Medical Solutions AG (FRA:M3V) Overvalued in 2026?
Based on GuruFocus' analysis, MeVis Medical Solutions AG stock appears to be overvalued.
The current stock price of €23.20 is trading 3% above its estimated GF Value™ of €22.52.
Key valuation signals for FRA:M3V:
Dividend Yield %: 4.09% (42% above median its 10-year median of 2.88)
GF Value™: €22.52 vs. price of €23.20 (3% above fair value)
Industry Position: 70.4% above the Healthcare Providers & Services median (#61 of 281)
No single metric tells the full story. See the FRA:M3V stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
MeVis Medical Solutions AG is a provider of medical software products. The company markets its products to equipment manufacturer of medical devices and providers of medical information technology platforms. Its segment includes Digital mammography and Other diagnostics. The Digital mammography segment develops and markets software products which assist in breast diagnostic imaging and intervention. Its Other diagnostics segment consists of digital radiology products. In addition, it also provides the general analysis of radiology images. The company's geographical area of operations includes the United States of America and Europe.
66GF Score
Get the complete analysis for FRA:M3V
Dividend Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
FRA:M3V has been successfully added to your 
